-
Mashup Score: 21
Treatment of pancreatic cancer often entails multiple modalities (e.g., chemotherapy, surgery, radiation) that vary in intensity, timing, and toxicity profiles. Some treatment options are only recommended for medically ‘fit’ patients regardless of age, yet formal fitness measures (such as the geriatric assessment [GA]) and patient preferences are seldom utilized during treatment decision-making.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet
-
Mashup Score: 16
Prioritising quality of life (QoL) or length of life is often necessary in the decision-making process for cancer care. This may be complicated in patients with limited life expectancy due to age and comorbidities. Older women with early breast cancer often receive non-standard care (primary endocrine therapy [PET] or omission of chemotherapy or radiotherapy) to reduce treatment morbidity and maintain QoL. We aimed to determine the perceived relative influence of QoL versus length of life in treatment decision making by older women with early (potentially curable) breast cancer.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Preferences for quality of life versus length of life in older women deciding about treatment for early breast cancer: A cross-sectional sub-analysis of the Bridging the Age Gap study https://t.co/PWUFz7JMe9 @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG https://t.co/asS2gHQNWX
-
-
Mashup Score: 23What are the determinants of functional decline in older adults with cancer? Results from the INCAPAC study - 10 day(s) ago
Older adults with cancer are exposed to greater difficulties in carrying out their daily activities due to cancer itself, its treatment, or both. The aim of this study was to describe functional decline after cancer diagnosis and to investigate the determinants of this decline among older individuals with cancer.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
What are the determinants of functional decline in older adults with cancer? Results from the INCAPAC study https://t.co/lVagWatxyt @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #FunctionalStatus #CohortStudies #CancerRegistries https://t.co/BuJKu6V1FA
-
-
Mashup Score: 19
Treatment of pancreatic cancer often entails multiple modalities (e.g., chemotherapy, surgery, radiation) that vary in intensity, timing, and toxicity profiles. Some treatment options are only recommended for medically ‘fit’ patients regardless of age, yet formal fitness measures (such as the geriatric assessment [GA]) and patient preferences are seldom utilized during treatment decision-making.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
The impact of electronic patient-reported outcomes presentation during multi-disciplinary tumor board on clinician discussion of older adults' fitness and preferences https://t.co/gaXbRyZesG @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier https://t.co/DwyI53JHOA
-
-
Mashup Score: 21
Continuing developments in oncology treatment and survivorship have emphasized rehabilitation as a recognized component of cancer care delivery [1]. Traditionally, cancer rehabilitation aims to restore physical, psychosocial, and cognitive functioning during and after cancer treatment [2]. However, rehabilitation may also be used to prevent or minimize the severity of anticipated treatment-related impairments [2].
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Perspectives on prehabilitation for older adults with cancer: A report from the International Society of Geriatric Oncology (SIOG) rehabilitation group https://t.co/5u7aeezXwL @RachelleBrick @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier
-
-
Mashup Score: 0
There is little information regarding the perceptions of older adults with cancer about intent of therapy, desire for disclosure of diagnosis and prognosis, treatment priorities, and influencing factors.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Treatment goals, desire for disclosure, and perception of cancer treatment outcomes in older patients with cancer: An observational study from a tertiary care center in India https://t.co/DFAdX8I7xg @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG https://t.co/q80HSh9lox
-
-
Mashup Score: 0
Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP) therapy is the standard of care for patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). However, detailed delineation of toxicity data is limited and has not been examined by age. We sought to examine adverse event data in patients receiving R-CHOP from the Cancer and Leukemia Group B (CALGB) 50303 trial to determine if there were differences in grade 3+ toxicities by age cohort or ECOG performance status (PS), and if outcome was impacted by age cohort or toxicity occurrence.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy https://t.co/XB5i9qIzfV @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #Toxicities https://t.co/3jdTIWn88I
-
-
Mashup Score: 0Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study - 2 month(s) ago
We aimed to evaluate the efficacy and safety of enfortumab vedotin therapy for a cohort of older Japanese patients with metastatic urothelial carcinoma compared to younger patients.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study https://t.co/kWCCTMziMS @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #AdverseEvent #OlderPatients https://t.co/itjVGv0uNL
-
-
Mashup Score: 13Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid leukemia and their caregivers: UR-GOAL 3 - 2 month(s) ago
Therapeutic advances have allowed more adults aged ≥60 years with acute myeloid leukemia (AML) to receive life-prolonging treatments, with improvement in overall survival. In contrast to other cancers, the onset of AML is often sudden, high-risk treatment decisions must be made quickly, and survival is often compromised due to aging-related conditions (e.g., functional impairments). Studies have demonstrated that up to 78 % of older adults with AML and their caregivers experience significant psychological distress.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid leukemia and their caregivers: UR-GOAL 3 https://t.co/PfjFULzPOz @MelissaLoh21 @HKlepinMD @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #SIOG #YoungSIOG #Elsevier #GeriatricAssessment https://t.co/FAm4vWe6oP
-
-
Mashup Score: 19Three lessons from “The Fox and the Grapes” to inform precision oncology in the older adult - 3 month(s) ago
Practical Applications:
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Three lessons from “The Fox and the Grapes” to inform precision oncology in the older adult https://t.co/hrwXev1pFk @chefaleixomd @ramsedhom @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier
-
The impact of electronic patient-reported outcomes presentation during multi-disciplinary tumor board on clinician discussion of older adults' fitness and preferences https://t.co/gaXbRyZesG @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier https://t.co/DwyI53JHOA